HR 340 · 119th CongressIn Committeecongress.gov ↗

The HCT/P Modernization Act of 2025

What this bill does

AI plain-language summary

This bill requires the Food and Drug Administration (FDA) to provide more information and education about how it regulates human cell and tissue products, which are medical articles made from human cells or tissues intended for use in people. The FDA must hold workshops to educate people involved in this industry and gather their input, create a public comment system, and report to Congress with recommendations about regulating these products. The bill also requires the FDA to publish educational materials on its website about a group called the Tissue Reference Group that helps answer questions about these products, and to annually publish information about how many companies have registered with the FDA and how many inspections have been conducted since 2019.

Introduced

January 13, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.